Intas aims Indian biosimilar between Lucentis and Avastin

India's fast-emerging pharmaceutical and biosimilar maker Intas Pharmaceuticals expects to fill a significant need with its Indian launch of Razumab, the world's first biosimilar version of ranibizumab, branded Lucentis by Novartis.